help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koumas, L.
Right arrow Articles by Phipps, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koumas, L.
Right arrow Articles by Phipps, R. P.
(American Journal of Pathology. 2003;163:1291-1300.)
© 2003 American Society for Investigative Pathology

Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes

Laura Koumas*, Terry J. Smith{dagger}, Steven Feldon{ddagger}, Neil Blumberg§ and Richard P. Phipps*¶||**

From the Departments of Environmental Medicine, Pediatrics,|| Microbiology and Immunology,* Ophthalmology,{ddagger} Pathology and Laboratory Medicine,§ and Obstetrics and Gynecology,** University of Rochester, Rochester, New York; and the Division of Molecular Medicine,{dagger} Harbor-UCLA Medical Center, Torrance, California

Fibroblasts represent a dynamic population of cells, exhibiting functional heterogeneity within and among tissues. Fibroblast heterogeneity also results from phenotypic differences and may arise from activation or differentiation processes taking place in the cells. We previously reported that human fibroblasts were heterogeneous with respect to surface Thy-1 expression and that separation into Thy-1+ and Thy-1- subsets resulted in functionally distinct subpopulations, leading to the concept of fibroblast subset specialization. In this report we investigated whether Thy-1+ and/or Thy-1- fibroblasts were capable of differentiating into myofibroblasts or lipofibroblasts. Fibroblast subsets were used from human myometrium and orbit to test this hypothesis. Only Thy-1+ human myometrial and orbital fibroblasts were capable of myofibroblast differentiation after treatment with TGFß or platelet concentrate supernatant, assessed by {alpha} smooth muscle actin expression. Interestingly, only Thy-1-, but not Thy-1+ subsets differentiated to lipofibroblasts, as determined by the accumulation of cytoplasmic lipid droplets after treatment with 15-deoxy-{Delta}12, 14-PGJ2 or ciglitazone. We propose that fibroblast Thy-1 display pre-determines lineage to a contractile or lipid-like phenotype in the human myometrium and orbit. This additional distinction between Thy-1+ and Thy-1- human fibroblast subtypes has important consequences in normal tissue homeostasis and in pathogenesis of orbital and myometrial diseases characterized by persistent myofibroblasts or fat accumulation, such as occurs in Graves’ ophthalmopathy, tissue fibrosis, abnormal wound healing, and scarring.





This article has been cited by other articles:


Home page
Cancer Res.Home page
N. M. Hawsawi, H. Ghebeh, S.-F. Hendrayani, A. Tulbah, M. Al-Eid, T. Al-Tweigeri, D. Ajarim, A. Alaiya, S. Dermime, and A. Aboussekhra
Breast Carcinoma-Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes
Cancer Res., April 15, 2008; 68(8): 2717 - 2725.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. R. Singh and I. P. Hall
Airway Myofibroblasts and Their Relationship with Airway Myocytes and Fibroblasts
Proceedings of the ATS, January 1, 2008; 5(1): 127 - 132.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Dezso, P. Jelnes, V. Laszlo, K. Baghy, C. Bodor, S. Paku, N. Tygstrup, H. C. Bisgaard, and P. Nagy
Thy-1 Is Expressed in Hepatic Myofibroblasts and Not Oval Cells in Stem Cell-Mediated Liver Regeneration
Am. J. Pathol., November 1, 2007; 171(5): 1529 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Mueller, F. A. Goumas, M. Affeldt, S. Sandtner, U. M. Gehling, S. Brilloff, J. Walter, N. Karnatz, K. Lamszus, X. Rogiers, et al.
Stromal Fibroblasts in Colorectal Liver Metastases Originate From Resident Fibroblasts and Generate an Inflammatory Microenvironment
Am. J. Pathol., November 1, 2007; 171(5): 1608 - 1618.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Zaitseva, B. J. Vollenhoven, and P. A.W. Rogers
Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium
Mol. Hum. Reprod., August 1, 2007; 13(8): 577 - 585.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Meltendorf, G. J. Burbach, J. Buhren, R. Bug, C. Ohrloff, and T. Deller
Corneal Femtosecond Laser Keratotomy Results in Isolated Stromal Injury and Favorable Wound-Healing Response
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2068 - 2075.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Nazareth, L. Broderick, M. R. Simpson-Abelson, R. J. Kelleher Jr., S. J. Yokota, and R. B. Bankert
Characterization of Human Lung Tumor-Associated Fibroblasts and Their Ability to Modulate the Activation of Tumor-Associated T Cells
J. Immunol., May 1, 2007; 178(9): 5552 - 5562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Y. Sanders, P. Kumbla, and J. S. Hagood
Enhanced Myofibroblastic Differentiation and Survival in Thy-1(-) Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 226 - 235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. E. Feldon, C. W. O'Loughlin, D. M. Ray, S. Landskroner-Eiger, K. E. Seweryniak, and R. P. Phipps
Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to Adipocytes
Am. J. Pathol., October 1, 2006; 169(4): 1183 - 1193.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. A. Rege and J. S. Hagood
Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis
FASEB J, June 1, 2006; 20(8): 1045 - 1054.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-J. Shih, S.-L. Liao, K.-T. Kuo, T. J. Smith, and L.-M. Chuang
Molecular Pathology of Muller's Muscle in Graves' Ophthalmopathy
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1159 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. S. Hagood, P. Prabhakaran, P. Kumbla, L. Salazar, M. W. MacEwen, T. H. Barker, L. A. Ortiz, T. Schoeb, G. P. Siegal, C. B. Alexander, et al.
Loss of Fibroblast Thy-1 Expression Correlates with Lung Fibrogenesis
Am. J. Pathol., August 1, 2005; 167(2): 365 - 379.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. Ishii, T. Sangai, K. Sugiyama, T. Ito, T. Hasebe, Y. Endoh, J. Magae, and A. Ochiai
In Vivo Characterization of Bone Marrow-Derived Fibroblasts Recruited into Fibrotic Lesions
Stem Cells, May 1, 2005; 23(5): 699 - 706.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Han and T. J. Smith
Induction by IL-1{beta} of Tissue Inhibitor of Metalloproteinase-1 in Human Orbital Fibroblasts: Modulation of Gene Promoter Activity by IL-4 and IFN-{gamma}
J. Immunol., March 1, 2005; 174(5): 3072 - 3079.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Zhou, J. S. Hagood, and J. E. Murphy-Ullrich
Thy-1 Expression Regulates the Ability of Rat Lung Fibroblasts to Activate Transforming Growth Factor-{beta} in Response to Fibrogenic Stimuli
Am. J. Pathol., August 1, 2004; 165(2): 659 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Kumar, M. J. Coenen, P. E. Scherer, and R. S. Bahn
Evidence for Enhanced Adipogenesis in the Orbits of Patients with Graves' Ophthalmopathy
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 930 - 935.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.